Literature DB >> 27943005

Skin manifestations of Cushing's syndrome.

Constantine A Stratakis1.   

Abstract

Among the most common diagnostic manifestations of Cushing's syndrome (CS) are those involving the skin; they include violaceous striae, facial acne, hirsutism, acanthosis nigricans (AN), fungal infections, hyperpigmentation (Hp) and easy bruisability. Fortunately, most resolve within a year or two after cure of CS, although light-colored striae can persist for years depending on the age of the patients. AN, Hp, and bruisability usually resolve within months after cure in almost all ages. Facial plethora (along with acne and other facial skin changes) is a typical sign of CS that is due to increased perfusion. It resolves immediately after curative therapy of CS. Typically, the severity of the manifestations does not correlate with the biochemical indices of the disease, pointing to age, gender, genetic and skin-type differences that determine the cutaneous manifestations of CS.

Entities:  

Keywords:  Acanthosis; Acne; Bruise; Cushing’s syndrome; Glucocorticoids; Hirsutism; Hyperpigmentation; Plethora; Skin; Striae

Mesh:

Year:  2016        PMID: 27943005      PMCID: PMC5181654          DOI: 10.1007/s11154-016-9399-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  32 in total

1.  Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects.

Authors:  K M Haapasaari; J Risteli; A Oikarinen
Journal:  Br J Dermatol       Date:  1996-07       Impact factor: 9.302

2.  Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.

Authors:  A J McMichael; C E Griffiths; H S Talwar; L J Finkel; E S Rafal; T A Hamilton; J J Voorhees
Journal:  Br J Dermatol       Date:  1996-07       Impact factor: 9.302

3.  Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes.

Authors:  N Meisler; S Shull; R Xie; G L Long; M Absher; J P Connolly; K R Cutroneo
Journal:  J Cell Biochem       Date:  1995-11       Impact factor: 4.429

Review 4.  Minimizing complications from systemic glucocorticosteroid use.

Authors:  L T Nesbitt
Journal:  Dermatol Clin       Date:  1995-10       Impact factor: 3.478

5.  Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome.

Authors:  Margaret F Keil; Jennifer Graf; Nirmal Gokarn; Constantine A Stratakis
Journal:  Clin Nutr       Date:  2011-12-07       Impact factor: 7.324

6.  Bone mineral density in women with depression.

Authors:  D Michelson; C Stratakis; L Hill; J Reynolds; E Galliven; G Chrousos; P Gold
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

7.  Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

Authors:  M A Magiakou; G Mastorakos; M T Gomez; S R Rose; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

8.  Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation.

Authors:  E A Bouzas; G Mastorakos; T C Friedman; M H Scott; G P Chrousos; M I Kaiser-Kupfer
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-12       Impact factor: 4.799

9.  Facial Plethora: Modern Technology for Quantifying an Ancient Clinical Sign and Its Use in Cushing Syndrome.

Authors:  Ali Afshari; Yasaman Ardeshirpour; Maya Beth Lodish; Evgenia Gourgari; Ninet Sinaii; Margaret Keil; Elena Belyavskaya; Charalampos Lyssikatos; Fatima A Chowdhry; Victor Chernomordik; Afrouz A Anderson; Thomas A Mazzuchi; Amir Gandjbakhche; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-08-24       Impact factor: 5.958

10.  Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing.

Authors:  M Brauchle; R Fässler; S Werner
Journal:  J Invest Dermatol       Date:  1995-10       Impact factor: 8.551

View more
  5 in total

1.  Metabolism and skin diseases.

Authors:  Christos C Zouboulis; Constantine A Stratakis; George P Chrousos; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  Cushing disease in a patient with nonbullous congenital ichthyosiform erythroderma: lessons in avoiding glucocorticoids in ichthyosis.

Authors:  Iris R Hartley; Julia Costa Beber Nunes; Maya Lodish; Constantine A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2019-08-27       Impact factor: 1.634

3.  Corticosterone Upregulates Gene and Protein Expression of Catecholamine Markers in Organotypic Brainstem Cultures.

Authors:  Carla L Busceti; Rosangela Ferese; Domenico Bucci; Larisa Ryskalin; Stefano Gambardella; Michele Madonna; Ferdinando Nicoletti; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2019-06-14       Impact factor: 5.923

4.  Difficult-to-diagnose diabetes in a patient treated with cyclophosphamide - the contradictory roles of immunosuppressant agents: a case report.

Authors:  Manuel García-Sáenz; Daniel Uribe-Cortés; Claudia Ramírez-Rentería; Aldo Ferreira-Hermosillo
Journal:  J Med Case Rep       Date:  2018-12-10

Review 5.  Toward a Diagnostic Score in Cushing's Syndrome.

Authors:  Leah T Braun; Anna Riester; Andrea Oßwald-Kopp; Julia Fazel; German Rubinstein; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.